Empire Life Investments’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-489,767
| Closed | -$20.3M | – | 98 |
|
|
2024
Q2 | $20.3M | Sell |
489,767
-27,790
| -5% | -$1.15M | 1.28% | 31 |
|
|
2024
Q1 | $28.1M | Sell |
517,557
-16,307
| -3% | -$884K | 1.72% | 19 |
|
|
2023
Q4 | $27.4M | Sell |
533,864
-285
| -0.1% | -$14.6K | 1.77% | 20 |
|
|
2023
Q3 | $31M | Sell |
534,149
-1,123
| -0.2% | -$65.2K | 2.27% | 15 |
|
|
2023
Q2 | $34.2M | Buy |
535,272
+3,811
| +0.7% | +$244K | 2.34% | 16 |
|
|
2023
Q1 | $36.8M | Sell |
531,461
-1,621
| -0.3% | -$112K | 2.62% | 11 |
|
|
2022
Q4 | $38.4M | Buy |
533,082
+171,129
| +47% | +$12.3M | 2.63% | 14 |
|
|
2022
Q3 | $25.7M | Buy |
361,953
+8,582
| +2% | +$610K | 1.96% | 20 |
|
|
2022
Q2 | $27.2M | Sell |
353,371
-119,522
| -25% | -$9.2M | 1.96% | 19 |
|
|
2022
Q1 | $34.5M | Sell |
472,893
-346
| -0.1% | -$25.3K | 2.21% | 14 |
|
|
2021
Q4 | $29.5M | Buy |
473,239
+68,423
| +17% | +$4.27M | 1.8% | 23 |
|
|
2021
Q3 | $24M | Sell |
404,816
-2,226
| -0.5% | -$132K | 1.57% | 26 |
|
|
2021
Q2 | $27.2M | Buy |
407,042
+12,947
| +3% | +$865K | 1.75% | 24 |
|
|
2021
Q1 | $24.9M | Buy |
394,095
+109,859
| +39% | +$6.94M | 1.71% | 24 |
|
|
2020
Q4 | $17.6M | Buy |
+284,236
| New | +$17.6M | 1.25% | 29 |
|
|
2020
Q1 | – | Sell |
-1,190
| Closed | -$76K | – | 109 |
|
|
2019
Q4 | $76K | Buy |
+1,190
| New | +$76K | 0.01% | 96 |
|
|
2017
Q4 | – | Sell |
-61,045
| Closed | -$3.89M | – | 101 |
|
|
2017
Q3 | $3.89M | Buy |
61,045
+494
| +0.8% | +$31.5K | 0.31% | 79 |
|
|
2017
Q2 | $3.37M | Hold |
60,551
| – | – | 0.29% | 75 |
|
|
2017
Q1 | $3.29M | Buy |
60,551
+8,499
| +16% | +$462K | 0.32% | 70 |
|
|
2016
Q4 | $2.96M | Buy |
+52,052
| New | +$2.96M | 0.24% | 69 |
|